Tandem diabetes care, inc. (TNDM)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Operating Activities
Net loss

-14,867

2,605

-2,901

-1,512

-22,992

3,688

-34,246

-59,360

-32,693

-11,406

-16,034

-21,801

-23,792

-14,823

-29,815

-18,325

-20,484

-12,090

-19,586

-19,534

-21,208

-18,466

-19,899

-19,197

-21,962

-23,613

-13,061

-15,300

-11,163

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

1,830

1,642

1,484

1,508

1,438

1,468

1,455

1,405

1,493

2,129

1,721

1,588

1,428

1,472

1,299

1,384

1,334

1,219

1,196

1,232

1,182

1,304

1,167

997

921

703

756

922

784

Interest expense related to amortization of debt discount and debt issuance costs

-

-

-

-

-

0

334

695

692

545

521

523

294

80

52

64

78

29

38

36

35

43

42

41

93

434

-136

13

283

Payment in kind interest accrual of notes payable

-

-

-

-

-

-

-

-

-

421

419

412

405

252

235

228

212

-

-

-

-

-

-

-

-

-

-

-

-

Provision for Doubtful Accounts

862

854

671

455

342

431

272

386

359

160

247

110

307

-34

65

229

372

78

92

-69

-31

83

4

47

54

130

48

51

44

Provision (benefit) for inventory obsolescence

-363

845

490

339

679

210

213

77

107

-290

51

134

131

-

-

-

-

-

-

-

-

0

0

-97

260

379

332

79

23

Change in fair value of common stock warrants

1,922

226

-2,321

424

12,746

-2,548

12,265

42,549

14,228

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,990

-272

453

2,830

Amortization of discount on short-term investments

66

263

136

72

94

244

-485

-239

-59

0

0

3

13

26

40

36

-17

-25

-16

19

18

20

12

15

6

-

-

-

-

Stock-based compensation expense

15,865

18,685

17,230

12,322

9,834

10,309

9,537

2,698

1,192

2,126

2,392

5,146

2,964

2,927

2,905

3,028

2,800

3,086

2,977

3,260

3,773

3,947

3,746

3,531

3,771

2,846

965

588

56

Other

19

-363

16

-1

27

-3

4

3

148

90

3

2

64

-41

68

-70

-35

-82

83

-17

-60

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

-153

332

Accounts receivable, net

8,292

2,110

-2,400

15,809

-1,821

13,935

8,048

1,522

-7,657

10,372

1,799

1,452

-3,178

2,940

-1,163

562

-4,590

7,126

-374

2,178

-2,457

1,892

1,484

986

-1,821

1,261

1,482

568

-151

Inventories, net

11,095

8,985

13,536

4,764

3,690

-4,004

-794

-1,616

-342

-3,144

4,241

2,182

2,615

-206

3,002

1,486

2,622

97

3,095

1,234

1,658

48

764

820

188

-226

1,220

1,124

2,506

Prepaid and other current assets

2,231

567

-2,516

1,497

1,036

753

2

76

745

-698

401

-2,002

468

1,058

243

593

572

-315

461

193

56

474

-1,196

686

118

706

-704

697

-805

Other long-term assets

383

193

-28

190

225

-13

-4

25

18

-57

33

-23

43

-6

-7

13

2

-3

-145

0

17

-

-

-

-

-

-

-

-

Accounts payable

4,294

1,779

4,925

-2,170

4,376

558

2,816

-79

-1,654

-2,475

969

2,278

-2,725

2,943

-1,440

711

1,020

1,131

836

34

1,354

-1,841

539

558

-481

1,016

-2

737

-893

Accrued expenses

-2,124

31

2,194

2,404

-553

-1

-348

1,080

366

296

1,780

-1,728

855

-353

-222

42

36

-474

673

-673

-260

1,656

-496

198

-385

-507

799

176

-126

Employee-related liabilities

-6,253

112

4,313

6,842

-6,982

6,801

3,589

3,130

-3,978

3,076

-1,709

1,059

1,447

-353

-416

1,414

-2,223

1,907

1,177

-112

-933

1,354

2,870

-1,077

699

1,154

780

881

1,068

Deferred revenue

1,524

1,002

1,048

1,678

861

896

739

90

349

231

-2,787

73

-1,423

-3,918

8,586

83

-141

-130

913

235

-37

202

124

132

-29

240

67

64

-1,844

Other current liabilities

431

1,881

3,385

1,070

-2,120

1,334

1,149

307

-356

169

249

-468

-382

-775

945

542

-139

1,729

242

113

-160

247

-581

35

-1,276

-420

976

-2,144

2,483

Deferred rent

-

-

-

-

-

-

-212

-174

-185

-

-159

-104

-162

567

-113

-243

-210

-162

-161

-157

-151

-150

-150

-94

-67

-90

-142

-147

-141

Other long-term liabilities

-1,704

2,214

1,213

2,541

1,444

1,334

430

238

365

356

-207

-277

-262

748

7

111

24

153

1

403

366

477

267

133

-67

510

-90

676

-333

Net cash used in operating activities

-20,631

19,442

23,019

3,568

-4,124

14,133

-3,457

-6,723

-12,272

-11,641

-19,018

-14,665

-20,812

-13,582

-18,154

-13,492

-15,945

-10,246

-14,338

-18,758

-15,422

-13,537

-13,581

-17,300

-16,960

-12,826

-10,955

-15,165

-8,810

Investing Activities
Purchases of short-term investments

9,727

38,265

52,143

31,250

42,914

23,003

60,050

31,500

9,000

-

-

-

-

4,732

3,233

9,216

13,441

12,720

8,478

19,894

39,099

5,245

26,027

6,996

28,833

-

-

-

-

Proceeds from maturities of short-term investments

30,859

-

-

-

43,700

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales of short-term investments

18,550

-

-

-

1,400

-

-

-

-

-8,500

0

3,250

5,250

12,050

11,200

13,000

13,750

23,250

21,750

21,950

21,500

-

-

-

-

-

-

-

-

Purchases of property and equipment

6,766

6,749

4,623

6,761

1,408

888

1,011

573

514

1,419

244

1,412

2,643

2,743

2,139

2,103

1,945

1,670

1,743

1,751

600

746

970

1,070

1,620

1,479

1,113

514

901

Purchase of patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

74

0

0

0

173

0

1,500

0

500

Net cash provided by investing activities

32,916

-20,901

-22,171

-14,661

778

-6,591

-46,811

-27,823

-9,514

-1,419

-244

1,838

2,607

4,575

5,828

1,681

-1,636

8,860

11,529

305

-18,273

7,509

-15,147

2,794

-30,626

-6,574

-2,613

-514

-1,401

Financing Activities
Proceeds from exercise of common stock warrants

7

0

1

262

64

39

372

22,652

6,512

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of notes payable, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

35,000

0

0

14,994

-

-

-

-

-

-

-

-

-0

-374

374

28,874

Restricted cash in connection with notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

2,000

Principal payments on notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

0

0

4,396

Proceeds from issuance of preferred stock for cash, net of offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27

-

-

-

-

Proceeds from public offerings, net of offering costs

-

-

-

-

-

0

108,921

-149

64,157

14,681

3,990

-460

21,595

-

-

-

-

0

0

11

64,851

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock under Company stock plans

11,474

6,418

7,033

8,531

1,898

-

-

-

-

-

-

-

266

729

32

1,451

109

1,269

93

1,814

217

-

-

-

-

2,560

5

1

8

Net cash provided by financing activities

11,481

6,418

7,034

8,793

1,962

1,957

22,047

22,511

70,669

14,681

3,990

-156

21,861

35,729

32

1,451

15,103

1,269

93

1,825

65,068

1,646

78

1,888

27

128,235

-1,013

16,375

22,486

Effect of foreign exchange rate changes on cash

-456

155

21

12

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

23,310

5,114

7,903

-2,288

-1,381

9,499

-28,221

-12,035

48,883

1,621

-15,272

-12,983

3,656

26,722

-12,294

-10,360

-2,478

-117

-2,716

-16,628

31,373

-4,382

-28,650

-12,618

-47,559

108,834

-14,582

694

12,274

Supplemental disclosures of cash flow information
Interest paid

-

-

-

-

-

4,964

1,057

2,405

2,379

2,005

1,989

1,956

1,926

1,196

1,106

1,090

1,009

729

881

872

863

569

881

869

1,050

448

1,104

1,436

1,125

Income taxes paid

91

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

88

-

-

-

-16

Supplemental schedule of non-cash investing and financing activities
Right-of-use assets obtained in exchange for operating lease obligations

8,805

190

0

8,392

3,053

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease incentive - lessor-paid tenant improvements

-

-

-

-

-

-

-

-

-

255

253

1,011

1,773

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt discount included in other long-term liabilities

-

-

-

-

-

-

-

4,137

827

-2,583

2,625

1,536

2,559

1,055

0

2

452

-

-

-

-

-

-

-

-

-

-

-

-

Common stock warrants issued in connection with term loan

-

-

-

-

-

-

-

-

-

0

0

0

3,331

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Public offering costs included in accounts payable

-

-

-

-

-

-

-

-

129

-

-

-

374

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment included in accounts payable

1,880

-350

2,245

109

130

68

-35

-125

217

20

12

-169

229

-301

207

154

441

823

-876

-128

1,638

743

-13

-90

149

-

-209

216

25

Common warrants issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

437